CSIMarket
 
Lexicon Pharmaceuticals Inc   (NASDAQ: LXRX)
 

Lexicon Pharmaceuticals Inc's Suppliers Performance

LXRX's Supply Chain




 
LXRX Costs vs Sales of Suppliers Growth Lexicon Pharmaceuticals Inc recorded an increase in cost of sales by 18.18 % year on year, relative to one quarter ago cost of sales fell by -63.89 % in Q2.

• More on LXRX Suppliers



Lexicon Pharmaceuticals Inc recorded increase in cost of sales by 18.18 % year on year, compare to one quarter ago cost of sales fell by -63.89 % in Q2.

• More on LXRX Suppliers




Lexicon Pharmaceuticals Inc's Comment on Supply Chain


The company sources raw materials for manufacturing active pharmaceutical ingredients (API) from multiple third-party suppliers in Asia and Europe. Third-party API contract manufacturers in these regions maintain sufficient stock to meet commercial and clinical requirements. API is stored at third-party facilities in North America and Asia and supplied to third-party drug product contract manufacturers in North America, who manufacture, package, and label finished commercial and clinical products. These contract manufacturers also procure excipients, components, and reagents necessary for production. Safety stock levels for API and drug products are maintained at multiple locations based on business needs and supply risk assessments. The current manufacturing network supports the production of commercial and clinical quantities of INPEFA and other drug candidates. A backup supplier for the API used in commercial INPEFA supplies is being established. The company relies on a sole-source third-party drug product contract manufacturer in North America for commercial INPEFA, with a backup supplier identified. A single third-party logistics provider with two distribution locations manages shipping and warehousing for commercial INPEFA supply.

Lexicon Pharmaceuticals Inc's Comment on Supply Chain


The company sources raw materials for manufacturing active pharmaceutical ingredients (API) from multiple third-party suppliers in Asia and Europe. Third-party API contract manufacturers in these regions maintain sufficient stock to meet commercial and clinical requirements. API is stored at third-party facilities in North America and Asia and supplied to third-party drug product contract manufacturers in North America, who manufacture, package, and label finished commercial and clinical products. These contract manufacturers also procure excipients, components, and reagents necessary for production. Safety stock levels for API and drug products are maintained at multiple locations based on business needs and supply risk assessments. The current manufacturing network supports the production of commercial and clinical quantities of INPEFA and other drug candidates. A backup supplier for the API used in commercial INPEFA supplies is being established. The company relies on a sole-source third-party drug product contract manufacturer in North America for commercial INPEFA, with a backup supplier identified. A single third-party logistics provider with two distribution locations manages shipping and warehousing for commercial INPEFA supply.







LXRX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Lexicon Pharmaceuticals Inc 785.59 41.47 -61.12 81
SUBTOTAL 0.00 0.00 0.00 -


Sources: Lexicon Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Lexicon Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.